DYAI · Healthcare · $17M
After-hours $0.48+2.36%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“매출은 1분기 약 100만 달러에서 2분기 96만 달러로 비슷했지만, 상반기 누적 매출은 전년보다 52% 늘었어요.”
In the company's words · 2026 2분기 earnings call